Clinical Trial Update: Granisetron Transdermal Patch for Prophylaxis of Nausea and Vomiting in Patients Receiving Oral Anticancer Agents [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating granisetron transdermal patch for prevention of chemotherapy-induced nausea and vomiting in patients receiving oral ant…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chemotherapy-induced Nausea and Vomiting

Drugs mentioned

• Granisetron transdermal patch (granisetron)

Snippet

Sponsor: Fudan University | Conditions: Chemotherapy-induced Nausea and Vomiting (CINV) | Phase 2 | Status: UNKNOWN